Clinical Trial Update: Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating NC-6004 (a cisplatin nanoparticle formulation) in combination with gemcitabine has completed testing in advanced solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Bladder Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• NC-6004 (cisplatin nanoparticle formulation)

Snippet

Sponsor: NanoCarrier Co., Ltd. | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-01-22